DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients treated on clinical trials

被引：0
|
作者：
Tran, Q. [1 ]
Upadhyaya, S. [2 ]
Billups, C. [1 ]
Onar-Thomas, A. [1 ]
Carey, S. [1 ]
Alom, M. [1 ]
Robinson, G. [1 ]
Ellison, D. [1 ]
Gajjar, A. [1 ]
Orr, B. [1 ]
机构：
[1] St Jude Childrens Res Hosp, Memphis, TN USA
[2] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 2023年 / 82卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
131
引用
收藏
页码：544 / 544
页数：1
相关论文
共 50 条
  • [41] Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy
    Kokoska, MS
    Piccirillo, JF
    ElMofty, SK
    Emami, B
    Haughey, BH
    Scholnick, SB
    CANCER, 1996, 78 (08) : 1693 - 1700
  • [42] Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine
    Fischer, Juergen R.
    Ohnmacht, Ute
    Rieger, Norman
    Zemaitis, Marius
    Stoffregen, Clemens
    Manegold, Christian
    Lahm, Harald
    LUNG CANCER, 2007, 56 (01) : 115 - 123
  • [43] Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide
    Nagane, Motoo
    Kobayashi, Keiichi
    Ohnishi, Akiko
    Shimizu, Saki
    Shiokawa, Yoshiaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (12) : 897 - 906
  • [44] Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials
    Carr, Louise
    Norris, Kevin
    Parker, Helen
    Nilsson-Takeuchi, Anna
    Bryant, Dean
    Amarasinghe, Harindra
    Kadalayil, Latha
    Else, Monica
    Pettitt, Andrew
    Hillmen, Peter
    Schuh, Anna
    Walewska, Renata
    Baird, Duncan M.
    Oscier, David G.
    Oakes, Christopher C.
    Gibson, Jane
    Pepper, Chris
    Strefford, Jonathan C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 2072 - 2076
  • [45] Telomere Length and DNA Methylation Epitype Both Provide Independent Prognostic Information in CLL Patients; Data from the UK CLL4, Arctic and Admire Clinical Trials
    Carr, Louise J.
    Norris, Kevin
    Parker, Helen
    Nilsson-Takeuchi, Anna
    Bryant, Dean J.
    Amarasinghe, Harindra Eranthi
    Kadalayil, Latha
    Else, Monica
    Wojdacz, Tomasz
    Pettitt, Andrew
    Hillmen, Peter
    Schuh, Anna
    Walewska, Renata
    Baird, Duncan M.
    Oscier, David Graham
    Oakes, Christopher C.
    Gibson, Jane
    Pepper, Chris
    Strefford, Jonathan C.
    BLOOD, 2023, 142
  • [46] Clinical outcomes and prognostic factors in 83 patients with pancreatic cancer treated in phase I clinical trials at MD Anderson Cancer Center
    Tsimberidou, Apostolia M.
    Vaklavas, Christos
    Wen, Sijin
    Hong, David
    Wheler, Jennifer
    Ng, Chaan S.
    Naing, Aung
    Uehara, Cynthia
    Wolff, Robert
    Kurzrock, Razelle
    CANCER RESEARCH, 2010, 70
  • [47] A clinical prognostic index for patients treated with erlotinib in National Cancer Institute of Canada clinical trials group study BR.21
    Florescu, Marie
    Hasan, Baktiar
    Seymour, Lesley
    Ding, Keyue
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : 590 - 598
  • [48] Clinical and prognostic significance of human papillomavirus DNA in the sperm or exfoliated cells of infertile patients and subjects with risk factors
    Foresta, Carlo
    Pizzol, Damiano
    Moretti, Afra
    Barzon, Luisa
    Palu, Giorgio
    Garolla, Andrea
    FERTILITY AND STERILITY, 2010, 94 (05) : 1723 - 1727
  • [49] Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials
    Chen, Yan-Ting
    Valent, Erik T.
    van Beers, Erik H.
    Kuiper, Rowan
    Oliva, Stefania
    Haferlach, Torsten
    Chng, Wee-Joo
    van Vliet, Martin H.
    Sonneveld, Pieter
    Larocca, Alessandra
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (01) : 127 - 134
  • [50] PROGNOSTIC SIGNIFICANCE OF MGMT PROMOTER METHYLATION STATUS IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA TREATED WITH BCNU WAFER IMPLANTATION: A PROSPECTIVE PATIENT COHORT
    Philippe, Metellus
    Isabelle, Nanni-Metellus
    Olivier, Chinot
    Frederic, Fina
    Stephane, Fuentes
    Henry, Dufour
    Marylin, Barrie
    L'Houcine, Ouafik
    Dominique, Figarella-Branger
    NEURO-ONCOLOGY, 2011, 13 : 56 - 56
12345